COMMUNIQUÉS West-GlobeNewswire
-
LTC ACO Demonstrates Continued Strength, Completing All 2024 Provider Payments
06/11/2025 -
ProKidney Presents Full Results from the Phase 2 REGEN-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025
06/11/2025 -
Channel Medsystems Surpasses 5,000 Cerene® Cryotherapy Procedures, Marking Milestone in Women’s Health Innovation
06/11/2025 -
Invitation to the presentation of ALK’s first nine months (Q3) 2025 results on Thursday, 13 November 2025
06/11/2025 -
Genmab Announces Financial Results for the Nine Months of 2025
06/11/2025 -
Growth in revenue and operating profit
06/11/2025 -
Zealand Pharma conference call on November 13 at 2pm CET (8am ET) to present third quarter 2025 financial results
06/11/2025 -
CROSSJECT : Information relative au nombre total de droits de vote et d'actions composant le capital social
06/11/2025 -
Vivoryon Therapeutics N.V. Presents Phase 2 Kidney Function and Biomarker Data at the American Society of Nephrology Kidney Week 2025
06/11/2025 -
Elixir Medical Highlights Results From “Real World” MY-IVL Study Demonstrating Performance of LithiX™ Hertz Contact (HC) Intravascular Lithotripsy System (IVL) in Treating Calcified Coronary Lesions
06/11/2025 -
Corza Medical Launches Customer Portal to Enhance the Digital Ordering Experience for Eye Care Professionals
06/11/2025 -
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 44 - 2025
06/11/2025 -
IPSEN - Buy-back programme - Art 5 of MAR - Week 44 - 2025
06/11/2025 -
EssilorLuxottica étend sa plateforme de solutions de gestion de la myopie avec les verres Essilor Stellest 2.0, des lunettes connectées et une solution innovante pour adresser la pré-myopie
06/11/2025 -
EssilorLuxottica expands its myopia management platform with Essilor Stellest 2.0 lenses, smart glasses and an innovative pre-myopia solution
06/11/2025 -
Novo Nordisk announces agreement with the U.S. Administration to bring GLP-1s to more Americans at a lower cost
06/11/2025 -
La campagne Raise Craze, un partenariat entre la Fondation du CUSM, The Beat 92.5 et Pink in the City, recueille 162,160 $ pour les soins contre le cancer du sein au CUSM
06/11/2025 -
Raise Craze, a partnership between the MUHC Foundation, The Beat 92.5, and Pink in the City, raised $162,160 for breast cancer care at the MUHC
06/11/2025 -
Healthcare Minus the Headache: RokketMed, A Solution to Finding the Care That Counts
06/11/2025
Pages